Discovery and in vitro characterization of a human anti-CD36 scFv

Discovery and in vitro characterization of a human anti-CD36 scFv

IntroductionCD36 is a membrane receptor that participates in the cellular uptake of fatty acids and lipid metabolism. CD36 overexpression favors progression of different pathologies, such as atherosclerosis and cancer. Thus, CD36 targeting has medicinal relevance. Herein, we aimed to identify human...

Full description

Saved in:

Bibliographic Details
Main Authors:	Cecilia Mata-Cruz, Sandra L. Guerrero-Rodríguez, Keyla Gómez-Castellano, Gregorio Carballo-Uicab, Juan Carlos Almagro, S. Mayra Pérez-Tapia, Marco A. Velasco-Velázquez
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Immunology
Subjects:	CD36 scFv antibodies cancer atherosclerotic cardiovascular disease phage display human antibodies
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1531171/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A New Antibody–Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia
by: Michela Flego, et al.
Published: (2025-01-01)

Seq2scFv: a toolkit for the comprehensive analysis of display libraries from long-read sequencing platforms
by: Marianne Bachmann Salvy, et al.
Published: (2024-12-01)

Reduction of monoclonal antibody viscosity using interpretable machine learning
by: Emily K. Makowski, et al.
Published: (2024-12-01)

Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies
by: Kristina M.J. Aertker, et al.
Published: (2024-12-01)

Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
by: Andrés de la Rosa, et al.
Published: (2025-01-01)

A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability
by: Fortunato Ferrara, et al.
Published: (2024-12-01)

Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
by: A. N. Chikaev, et al.
Published: (2021-09-01)

Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β
by: Rebecca Faresjö, et al.
Published: (2024-12-01)

Synthetic integrin antibodies discovered by yeast display reveal αV subunit pairing preferences with β subunits
by: Yuxin Hao, et al.
Published: (2024-12-01)

Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methods
by: Stefan Dübel
Published: (2024-12-01)

scFv Antibody: Principles and Clinical Application
by: Zuhaida Asra Ahmad, et al.
Published: (2012-01-01)

Engineered ipilimumab variants that bind human and mouse CTLA-4
by: Brett Robison, et al.
Published: (2025-12-01)

The use of bacterial culture for Leptospirosis di- agnosis in female water buffaloes
by: Rosaura Pérez-Gil, et al.
Published: (2023-11-01)

Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge
by: M. Biddle, et al.
Published: (2024-12-01)

Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01)

Electrostatic properties of human germlines and biodistribution of small biologics
by: Leticia Maria De Souza Cordeiro, et al.
Published: (2024-12-01)

Clinical significance of establishing a red blood cell alloantibody detection database
by: XIAO Xiao, et al.
Published: (2025-01-01)

Assessment of infectious diseases in commercial frozen semen straws of water buffalo bulls. Preliminary results
by: Rosaura Pérez-Gil
Published: (2023-11-01)

A CD36-based prediction model for sepsis-induced myocardial injury
by: Yun Xie, et al.
Published: (2025-04-01)

Biparatopic antibodies: therapeutic applications and prospects
by: David L. Niquille, et al.
Published: (2024-12-01)

Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies
by: Ugochi Ebinama, et al.
Published: (2025-01-01)

Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
by: Chengcheng Zhang, et al.
Published: (2023-05-01)

Do antibody CDR loops change conformation upon binding?
by: Chu’nan Liu, et al.
Published: (2024-12-01)

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
by: Masaud Shah, et al.
Published: (2025-01-01)

Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
by: Chengcheng Zhang, et al.
Published: (2025-01-01)

ZFP36 Regulates Vascular Smooth Muscle Contraction and Maintains Blood Pressure
by: Xiuru Cui, et al.
Published: (2025-01-01)

Six events that shaped antibody approvals in oncology
by: Suman Paul, et al.
Published: (2025-02-01)

Identification of rare anti-f alloantibody in a tertiary care center in India
by: Gunjan Bhardwaj, et al.
Published: (2024-01-01)

TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner
by: Arun Chhetri, et al.
Published: (2025-02-01)

Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy
by: Apisitt Thaiprayoon, et al.
Published: (2025-01-01)

The disappearing COVID-Naïve Population and comparative Roche vs. Abbott Test sensitivity: evidence from antibody seroprevalence in Milwaukee County, Wisconsin
by: Lorenzo Franchi, et al.
Published: (2024-11-01)

The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective
by: Onder Onen, et al.
Published: (2020-12-01)

IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release
by: John S. Schardt, et al.
Published: (2024-12-01)

IgH Diversity In an Individual With Only One Million B Lymphocytes
by: Ada Lee, et al.
Published: (1993-01-01)

The Effect of Calcitonin Gene-Related Peptide Monoclonal Antibodies on Quality of Life among Migraine Patients: Pilot Study at the Hospital of Lithuanian University of Health Sciences Kaunas Clinics
by: Monika Remenčiūtė, et al.
Published: (2024-05-01)

Antibody-mediated degradation of 4R-tau restores mitochondrial membrane polarization in human induced pluripotent stem cell-derived neurons with the MAPT 10+16 mutation
by: Dale O. Starkie, et al.
Published: (2024-12-01)

Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis
by: Ning Jin, et al.
Published: (2025-03-01)

RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties
by: Barnabas Nyesiga, et al.
Published: (2024-12-01)

T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics
by: Ruoxuan Sun, et al.
Published: (2024-12-01)

Characterization of two neutralizing monoclonal antibodies with conformational epitopes against porcine deltacoronavirus
by: Wan Lu, et al.
Published: (2025-01-01)